• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    BeiGene, Ontada Enter Strategic Oncology Alliance

    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Qosina

    Biosynth Carbosynth
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Qosina

    Biosynth Carbosynth
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Emendo Biotherapeutics Achieves Takeda Milestone

    Funds will be used to further advance Emendo's nuclease discovery platform and portfolio development programs

    Related CONTENT
    • Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer
    • Takeda Breaks Ground on New Manufacturing Facility
    • KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    • Imvax Appoints Sean Hemingway Chief Operating Officer
    • Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
    08.20.19
    Emendo Biotherapeutics has achieved the first milestone under its alliance with Takeda Pharmaceutical Co., resulting in the transfer of the second half of the investment from Takeda to Emendo.

    Emendo has executed two agreements with Takeda, including an investment in convertible notes from Takeda Ventures, Inc., the corporate venture arm of Takeda and a licensing option agreement that grants Takeda the option to use OMNI, Emendo's nuclease program to edit two genes as part of its R&D efforts. Additionally, Emendo will apply its nuclease engineering platform to optimize the OMNI nuclease on Takeda's chosen genes.

    The funds received will be used to further advance Emendo's nuclease discovery platform and portfolio development programs, continuing the optimization of its newly discovered panel of CRISPR-OMNI nucleases.
    Emendo's OMNI enables extremely specific gene editing which minimizes off target cuts and allows for highly focused therapeutic intervention in complex genetic diseases. The milestone demonstrates Emendo’s ability to discover novel CRISPR nucleases, OMNI nucleases that show high activity in mammalian cells.

    Emendo's chief executive officer, David Baram, said, "We're very pleased with the progress we have seen with this project and with the exciting discoveries of novel CRISPR nucleases with high activity. It has been very effective to collaborate with an innovative company such as Takeda as it allows us to factor in the perspective of a large pharmaceutical company while discovering and designing gene-editing machineries.”
    Related Searches
    • it
    • chief executive officer
    • Development
    • discovery
    Suggested For You
    Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer
    Takeda Breaks Ground on New Manufacturing Facility Takeda Breaks Ground on New Manufacturing Facility
    KemPharm Receives $10M Milestone for FDA Approval of Azstarys KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    Imvax Appoints Sean Hemingway Chief Operating Officer Imvax Appoints Sean Hemingway Chief Operating Officer
    Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
    Evotec, Takeda Enter Multi-RNA Target Alliance Evotec, Takeda Enter Multi-RNA Target Alliance
    Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
    Evozyne, Takeda Ink Strategic Protein Design Agreement Evozyne, Takeda Ink Strategic Protein Design Agreement
    Catalent Appoints Minakuchi Facility GM Catalent Appoints Minakuchi Facility GM
    XOMA Earns $2M Takeda Milestone XOMA Earns $2M Takeda Milestone
    Pii Appoints Business Development Director Pii Appoints Business Development Director
    Takeda Ireland Implements Werum’s PAS-X MES Takeda Ireland Implements Werum’s PAS-X MES
    Kamada, Takeda Discuss GLASSIA Manufacturing Transition Kamada, Takeda Discuss GLASSIA Manufacturing Transition
    Sosei Heptares, Takeda Enter R&D Partnership Sosei Heptares, Takeda Enter R&D Partnership
    PRA Health Sciences Buys Out Joint Venture in Japan PRA Health Sciences Buys Out Joint Venture in Japan

    Related Breaking News

    • Breaking News | Promotions & Moves
      Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer

      Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer

      Hairiri will oversee clinical development efforts for the company’s pipeline of therapies to treat rare diseases.
      09.10.21

    • Breaking News | Facilities | Industry News
      Takeda Breaks Ground on New Manufacturing Facility

      Takeda Breaks Ground on New Manufacturing Facility

      The $126 million investment increases the site’s capacity to manufacture additional products for the rare disease community.
      08.05.21

    • Breaking News | Drug Development | Drug Discovery
      KemPharm Receives $10M Milestone for FDA Approval of Azstarys

      KemPharm Receives $10M Milestone for FDA Approval of Azstarys

      Is eligible to receive an additional near-term $10 million milestone payment following DEA scheduling of SDX.
      Charles Sternberg, Assistant Editor 04.22.21


    • Breaking News | Promotions & Moves
      Imvax Appoints Sean Hemingway Chief Operating Officer

      Imvax Appoints Sean Hemingway Chief Operating Officer

      Hemingway brings more than 25 years of experience in biological manufacturing and supply chain.
      Kristin Brooks 04.08.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.
      Tim Wright, Editor, Contract Pharma 04.07.21

    Loading, Please Wait..
    Trending
    • Novavax Submits EUA For Protein-based COVID-19 Vax Booster
    • Gilead Sciences To Acquire MiroBio For $405M
    • Thermo Fisher Expands NY Cell Culture Media Manufacturing Site
    • Almac Invests $65M To Expand North American HQ
    • Pfizer, Neurocrine Terminate Collaboration
    Breaking News
    • Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    • BeiGene, Ontada Enter Strategic Oncology Alliance
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Indorama Ventures Posts Record 2Q 2022 Results
    Advanced Polymer Coatings Strikes Series of New Tanker Deals
    Barentz Named Distributor for Pilot Chemical Segments in US and Canada
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spartech Promotes Three Staff Members
    Elisabeth Lackner Named Chief Scientific Officer at Element Materials Technology
    Natech Plastics Purchases Three New Injection Molding Machines
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    BeiGene, Ontada Enter Strategic Oncology Alliance
    AskBio Appoints Clinical Ops Executives
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Mary Kay Supports International Women's Forum's Latest Research
    Vegamour Launches in the UK
    Maelys Rolls Out to Ulta Beauty
    Happi

    Latest Breaking News From Happi

    Dr. Bronner’s Releases 2022 All-One! Report, ‘Leading with Heart’
    Indeed Labs Skin Care Launches at Target
    In-Cosmetics Asia Returns to Bangkok to Deliver Look at Market Trends and Ingredient Innovations
    Ink World

    Latest Breaking News From Ink World

    BASF Breaks Ground on Riverfront Park in East Newark
    Roland DG Corporation to Relocate HQ to Miyakoda, Japan
    Gallus Launches Gallus One, Its First Fully Digital Inkjet Label Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Schreiner ProTech develops nameplate-integrated PCS solution
    Pro Label Inc. installs first Mark Andy DSiQ hybrid press
    Gallus launches Gallus One inkjet label press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Daio Paper Acquires Pet Care Products Manufacturer
    Honest Reports Increased Revenue
    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FundamentalVR Raises $20 Million in Series B Funding
    Bioventus Achieves Strong Growth in Q2 2022
    Bone Void Fillers Market Growing at 6%
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire
    Applied Materials CTO Dr. Om Nalamasu Receives IEEE Frederik Philips Award
    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login